TOFACITINIB
NDC 71085-099, Tofacitinib, solution, from IPG Pharmaceuticals, Inc.
- Product NDC
- 71085-099
- Status
- Listed
- Labeler
- IPG Pharmaceuticals, Inc
- Dosage form
- SOLUTION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA219370
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/71085-099 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TOFACITINIB CITRATE1 mg/mL
Pharmacologic classes
Janus Kinase Inhibitor [EPC]; Janus Kinase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 71085-099-24 | 71085009924 | 1 BOTTLE in 1 CARTON (71085-099-24) / 240 mL in 1 BOTTLE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/cd1b61bf-de03-4198-89f6-f3952b79d2c2
Use it
Look up 71085-099 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/71085-099 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 71085-099. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.